Article

Dr. Michael Sherman Discusses Companion Diagnostics

In this video, Dr. Michael Sherman, Senior Vice President and Chief Medical Officer at Harvard Pilgrim Heath Care, discusses the evolution of companion diagnostic testing, and some of the concerns with cost and coding.

In this video, Dr. Michael Sherman, Senior Vice President and Chief Medical Officer at Harvard Pilgrim Heath Care, discusses the evolution of companion diagnostic testing, and some of the concerns with cost and coding.

This video was taken at the 4th Annual Forum for Payers on Personalized Medicine conference in Washington, DC, on March 12, 2012.

Related Videos
Hans Lee, MD
Screenshot of an interview with Amir Ali, PharmD, BCOP
Mansi Shah, MD, assistant professor, Rutgers Cancer Institute of New Jersey
Alvaro Alencar, MD, associate professor of clinical medicine, chief medical officer, University of Miami Sylvester Comprehensive Cancer Center
Divya Gupta, MD
Dr Cesar Davila-Chapa
Matias Sanchez, MD
Sandra Cuellar, PharmD
Matias Sanchez, MD
Screenshot of an interview with Nadine Barrett, PhD
Related Content
Dr Alice Lee
December 11th 2024

Revealing Ovarian Cancer Survival Gaps Among Asian American Subgroups

Brooke McCormick
Alice W. Lee, PhD, MPH, of California State University, Fullerton, discusses her study on ovarian cancer survival disparities among disaggregated Asian American subgroups, emphasizing the need for a subgroup-specific approach in cancer research.
managed care cast logo
December 5th 2024

Advancing Women's Health: CVS Health Leader on Access, Technology, and Breaking Stigmas

Brooke McCormick
On this episode of Managed Care Cast, we speak with CVS Health's vice president and chief medical officer for women's health and genomics about advancements and challenges in women's health, focusing on care access, technology, and maternal outcomes.
Screenshot of an interview with Robert Rifkin, MD
December 11th 2024

Prophylactic Tocilizumab Could Increase Community Access to Bispecifics for MM

Laura Joszt, MA Luke Halpern
By reducing cytokine release syndrome and neurotoxicity, prophylactic tocilizumab could facilitate safe outpatient administration of bispecifics to treat multiple myeloma (MM), explained Robert Rifkin, MD.
managed care cast logo
November 27th 2024

Operationalizing Bispecifics in Multiple Myeloma

Mary Caffrey Laura Joszt, MA
Tyler Sandahl, PharmD, of Mayo Clinic, and Michael Byrne, DO, of Tennessee Oncology, discuss practical advice for bringing bispecifics to the community.
Bhuvana Sagar, MD
December 9th 2024

What Do Liquid Biopsies Add to Value-Based Cancer Care?

Hayden E. Klein
Payers want to make sure patients are getting biopsies done so they can get on the right therapies, said Bhuvana Sagar, MD, Oncology Consultants.
Highlights from ASPC Congress 2024 | Image Credit: venngage.com
December 9th 2024

ICYMI: Highlights From ASPC Congress 2024

Brooke McCormick
The top 5 most-viewed content from this year's American Society for Preventive Cardiology (ASPC) Congress on Cardiovascular Disease (CVD) Prevention included interviews with Robert Kushner, MD, MS, and Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC, as well as coverage on multiple areas of cardiovascular medicine.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo